Exploring the potential of gemcitabine-metal–organic frameworks in combating pancreatic cancer under ketogenic conditions
Abstract Background Inadequate treatment responses, chemotherapy resistance, significant heterogeneity, and lengthy treatment durations create an urgent need for new pancreatic cancer therapies. This study aims to investigate the effectiveness of gemcitabine-loaded nanoparticles enclosed in an organ...
Saved in:
Main Authors: | Samira Nekoufar, Marjan Ghorbani, Sahar Safaei, Gholamreza Alinezhadi Khosroushahi, Farzad Izak Shirian, Behzad Baradaran, Masoumeh Tavakoli-Yaraki |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-024-13397-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obtaining a pancreatic cancer cell line stably expressing doxycycline-dependent endonuclease Cas9
by: A.K. Nurgalieva, et al.
Published: (2018-09-01) -
Evaluation of Anti-Cancer, Pro-Apoptotic, and Anti-Metastatic Effects of Synthetic Analogue Compound 2-Imino-7-Methoxy-4-(4-fluorophenyl)-2H-1,3-Thiazino [3,2-a] Benzimidazole on Pancreatic PaCa-2 and Melanoma A375 Cancer Cells
by: Mpho Ndou, et al.
Published: (2025-01-01) -
Gemcitabine combined with baicalein exerts antiviral activity against PEDV by inhibiting the entry and replication phases
by: Yingge Zheng, et al.
Published: (2025-02-01) -
Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells
by: MENG Zihe, et al.
Published: (2025-01-01) -
An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
by: REN Jiaqiang, et al.
Published: (2024-12-01)